{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-071792","form_type":"8-K","ticker":"CARM","cik":"0001485003","company_name":"Carisma Therapeutics Inc.","filed_at":"2024-06-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.616322+00:00","generated_at":"2026-06-01T04:17:55.287020+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Carisma grants retention options: 125K shares CEO, 85K each CFO/CSO, vesting over 2 years","bullets":["CEO Steven Kelly receives option for 125,000 shares; CFO Richard Morris and CSO Michael Klichinsky each get 85,000 shares.","Exercise price equals closing price on June 17, 2024 grant date; options vest in two equal installments on first and second anniversaries.","Grants approved by Compensation Committee to incentivize retention during implementation of revised operating plan.","Company intends to make additional retention grants to other employees under the same plan."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-071792","json":"https://secwatch.observer/filing/0001104659-24-071792.json","markdown":"https://secwatch.observer/filing/0001104659-24-071792.md","text":"https://secwatch.observer/filing/0001104659-24-071792.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1485003/000110465924071792/0001104659-24-071792-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1485003/000110465924071792/tm2417340d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:17:55.287020+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}